CareVax Vaccine Tracking Program Launches

CareVax Vaccine tracking program designed to support the millions of individuals that will receive the COVID-19 vaccine has been launched by Care Angel.

CareVax patients will be given access to vaccine and COVID-19 education through ANGEL, a digital workforce of virtual nurse assistants that gathers clinical and non-clinical information, and when necessary, automatically triages users to the appropriate healthcare resources to address post-inoculation care needs. Powered by the company’s SmartCare Ecosystem Platform, ANGEL has the ability to augment the capacity of already exhausted clinical resources by 100X+ or more in order to manage and monitor for COVID-19 and vaccination symptoms for populations at scale, using omni-channels such as phone, text and chat.

“Before the pandemic, there had been already a massive global shortage of nurses, providers and family caregivers. This unprecedented global health crisis has exacerbated these human resources beyond capacity and caused an unnecessary caregiving burden leading to unrelenting suffering, deaths, long-term health and mental health issues, not to mention tremendous isolation for the aging, the sick and neediest populations,” said Lena Nikolnikov, Vice President of Product & Clinical Solutions at Care Angel.

CareVax is being released in the US first, internationally in early Q1, and is poised to work with government public health agencies at the federal, state, local county, and city levels offering a data-driven solution that can provide real-time analytic, surveillance and market intelligence in order to make more informed care decisions.

The program can be deployed stand alone or along with Care Angel’s HEALS COVID engagement and tracking offerings for employers and schools intended to help track and monitor at-risk populations, including exposure to COVID-19 positive cases and the need to quarantine. The initiative empowers vulnerable individuals with personalized health management, monitoring, education, contact tracing and triage to testing as well as care navigation.

Demand for scalable, quickly deployable solutions to manage large populations has accelerated due to the combination of the COVID-19 pandemic, vaccination distribution and the shortage of providers and care teams, domestically and across the world.

“After millions of calls and texts tracking COVID-19 in 2020, we see 2021 as a pivotal year for Care Angel to help globally as the critical need for resources that can deliver meaningful healthcare conversations at scale has been thrust into the global spotlight,” said Wolf Shlagman, CEO of Care Angel. “Sitting squarely at the intersection of digital health, telemedicine, AI and COVID-19, working with some of the largest health organizations on the planet, we are proud to already be having a noticeable impact on public health and the health and safety of society’s most vulnerable populations.”

Care Angel partners with large health plans, providers, health systems, pharma and government agencies to tackle some of the most challenging and costly elements of healthcare, namely, care management, health monitoring and reporting for vulnerable and at-risk populations.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”